Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) inevitably develop mineral and bone disorders (CKD–MBD), which negatively impact their survival and quality of life. For a better understanding of underlying pathophysiology and identification of novel therapeutic approaches, mouse models are essential. CKD...

Full description

Bibliographic Details
Main Authors: Ariane Zaloszyc, Julie Bernardor, Justine Bacchetta, Gilles Laverny, Claus Peter Schmitt
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/6/5325
_version_ 1797611309380927488
author Ariane Zaloszyc
Julie Bernardor
Justine Bacchetta
Gilles Laverny
Claus Peter Schmitt
author_facet Ariane Zaloszyc
Julie Bernardor
Justine Bacchetta
Gilles Laverny
Claus Peter Schmitt
author_sort Ariane Zaloszyc
collection DOAJ
description Patients with chronic kidney disease (CKD) inevitably develop mineral and bone disorders (CKD–MBD), which negatively impact their survival and quality of life. For a better understanding of underlying pathophysiology and identification of novel therapeutic approaches, mouse models are essential. CKD can be induced by surgical reduction of a functional kidney mass, by nephrotoxic compounds and by genetic engineering specifically interfering with kidney development. These models develop a large range of bone diseases, recapitulating different types of human CKD–MBD and associated sequelae, including vascular calcifications. Bones are usually studied by quantitative histomorphometry, immunohistochemistry and micro-CT, but alternative strategies have emerged, such as longitudinal in vivo osteoblast activity quantification by tracer scintigraphy. The results gained from the CKD–MBD mouse models are consistent with clinical observations and have provided significant knowledge on specific pathomechanisms, bone properties and potential novel therapeutic strategies. This review discusses available mouse models to study bone disease in CKD.
first_indexed 2024-03-11T06:27:04Z
format Article
id doaj.art-6b812348f30e45188fb907d6ce1499cf
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T06:27:04Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6b812348f30e45188fb907d6ce1499cf2023-11-17T11:32:19ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01246532510.3390/ijms24065325Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney DiseaseAriane Zaloszyc0Julie Bernardor1Justine Bacchetta2Gilles Laverny3Claus Peter Schmitt4Service de Pédiatrie 1, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, FranceService de Néphrologie Pédiatrique, CHU de Nice, Hôpital Archet, 06202 Nice, FranceINSERM UMR S1033 Research Unit, 69008 Lyon, FranceInstitut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, FranceCenter for Pediatric and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, GermanyPatients with chronic kidney disease (CKD) inevitably develop mineral and bone disorders (CKD–MBD), which negatively impact their survival and quality of life. For a better understanding of underlying pathophysiology and identification of novel therapeutic approaches, mouse models are essential. CKD can be induced by surgical reduction of a functional kidney mass, by nephrotoxic compounds and by genetic engineering specifically interfering with kidney development. These models develop a large range of bone diseases, recapitulating different types of human CKD–MBD and associated sequelae, including vascular calcifications. Bones are usually studied by quantitative histomorphometry, immunohistochemistry and micro-CT, but alternative strategies have emerged, such as longitudinal in vivo osteoblast activity quantification by tracer scintigraphy. The results gained from the CKD–MBD mouse models are consistent with clinical observations and have provided significant knowledge on specific pathomechanisms, bone properties and potential novel therapeutic strategies. This review discusses available mouse models to study bone disease in CKD.https://www.mdpi.com/1422-0067/24/6/5325CKDmiceCKD–MBDrenal osteodystrophy
spellingShingle Ariane Zaloszyc
Julie Bernardor
Justine Bacchetta
Gilles Laverny
Claus Peter Schmitt
Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
International Journal of Molecular Sciences
CKD
mice
CKD–MBD
renal osteodystrophy
title Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
title_full Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
title_fullStr Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
title_full_unstemmed Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
title_short Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
title_sort mouse models of mineral bone disorders associated with chronic kidney disease
topic CKD
mice
CKD–MBD
renal osteodystrophy
url https://www.mdpi.com/1422-0067/24/6/5325
work_keys_str_mv AT arianezaloszyc mousemodelsofmineralbonedisordersassociatedwithchronickidneydisease
AT juliebernardor mousemodelsofmineralbonedisordersassociatedwithchronickidneydisease
AT justinebacchetta mousemodelsofmineralbonedisordersassociatedwithchronickidneydisease
AT gilleslaverny mousemodelsofmineralbonedisordersassociatedwithchronickidneydisease
AT clauspeterschmitt mousemodelsofmineralbonedisordersassociatedwithchronickidneydisease